Chapter 16. History of Drug Regulation in the United Kingdom

  1. John P Griffin BSc, PhD, MBBS, FRCP, FRCPath, FFPM1,
  2. John O'Grady MD, FRCP, FFPM, FBIRA, MRCPath2
  1. John P Griffin,
  2. Rashmi R Shah

Published Online: 25 OCT 2007

DOI: 10.1002/9780470987391.ch16

The Textbook of Pharmaceutical Medicine, Fifth Edition

The Textbook of Pharmaceutical Medicine, Fifth Edition

How to Cite

Griffin, J. P. and Shah, R. R. (2007) History of Drug Regulation in the United Kingdom, in The Textbook of Pharmaceutical Medicine, Fifth Edition (eds J. P. Griffin and J. O'Grady), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987391.ch16

Editor Information

  1. 1

    Director, Asklepieion Consultancy Ltd., Visiting Professor, University of Surrey Postgraduate Medical School, Former Director, Association of the British Pharmaceutical Industry, London, Formerly Professional Head of the Medicines Division, DHSS, London

  2. 2

    Visiting Professor of Clinical Pharmacology, University of London

Publication History

  1. Published Online: 25 OCT 2007
  2. Published Print: 15 DEC 2005

ISBN Information

Print ISBN: 9780727918406

Online ISBN: 9780470987391

SEARCH

Keywords:

  • drug regulation;
  • united kingdom;
  • thalidomide disaster;
  • committee on safety of drugs;
  • clinical trial certificate

Summary

This chapter contains sections titled:

  • Introduction

  • The Thalidomide Disaster and its Immediate Aftermath

  • Voluntary Controls in the United Kingdom (1963–71)

  • The Medicines Act 1968

  • Statutory Controls in the United Kingdom (1971 and thereafter)

  • General Safety Measures

  • Medicines Control Agency

  • The Medicines and Healthcare products Regulatory Agency (MHRA)

  • European dimensions

  • International Dimensions

  • Conclusions